» Articles » PMID: 37450239

Advances in Regulation and Function of Stearoyl-CoA Desaturase 1 in Cancer, from Bench to Bed

Overview
Specialties Biology
Science
Date 2023 Jul 14
PMID 37450239
Authors
Affiliations
Soon will be listed here.
Abstract

Stearoyl-CoA desaturase 1 (SCD1) converts saturated fatty acids to monounsaturated fatty acids. The expression of SCD1 is increased in many cancers, and the altered expression contributes to the proliferation, invasion, sternness and chemoresistance of cancer cells. Recently, more evidence has been reported to further support the important role of SCD1 in cancer, and the regulation mechanism of SCD1 has also been focused. Multiple factors are involved in the regulation of SCD1, including metabolism, diet, tumor microenvironment, transcription factors, non-coding RNAs, and epigenetics modification. Moreover, SCD1 is found to be involved in regulating ferroptosis resistance. Based on these findings, SCD1 has been considered as a potential target for cancer treatment. However, the resistance of SCD1 inhibition may occur in certain tumors due to tumor heterogeneity and metabolic plasticity. This review summarizes recent advances in the regulation and function of SCD1 in tumors and discusses the potential clinical application of targeting SCD1 for cancer treatment.

Citing Articles

SREBF1-based metabolic reprogramming in prostate cancer promotes tumor ferroptosis resistance.

Wei G, Huang Y, Li W, Xie Y, Zhang D, Niu Y Cell Death Discov. 2025; 11(1):75.

PMID: 39988626 PMC: 11847930. DOI: 10.1038/s41420-025-02354-7.


HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy.

Tang Z, Qian Y, Wang N, Chen Y, Huang H, Zhang J Int J Med Sci. 2025; 22(1):140-157.

PMID: 39744172 PMC: 11659835. DOI: 10.7150/ijms.98334.


Comprehensive analysis of stearoyl-coenzyme A desaturase in prostate adenocarcinoma: insights into gene expression, immune microenvironment and tumor progression.

Wang J, Ying L, Xiong H, Zhou D, Wang Y, Che H Front Immunol. 2024; 15:1460915.

PMID: 39351232 PMC: 11439642. DOI: 10.3389/fimmu.2024.1460915.


Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL3.

Liu W, Deng J, Tao X, Peng Y, Chen X, Qu X Int J Oncol. 2024; 65(4).

PMID: 39155877 PMC: 11374152. DOI: 10.3892/ijo.2024.5680.


Molecular mechanisms of ferroptosis and its effects on bladder cancer.

Li R, Ning Y, Yuan Y, Yang X Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024; 49(2):286-295.

PMID: 38755725 PMC: 11103069. DOI: 10.11817/j.issn.1672-7347.2024.230352.


References
1.
Ackerman D, Simon M . Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol. 2014; 24(8):472-8. PMC: 4112153. DOI: 10.1016/j.tcb.2014.06.001. View

2.
Ackerman D, Tumanov S, Qiu B, Michalopoulou E, Spata M, Azzam A . Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation. Cell Rep. 2018; 24(10):2596-2605.e5. PMC: 6137821. DOI: 10.1016/j.celrep.2018.08.015. View

3.
ALJohani A, Syed D, Ntambi J . Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism. Trends Endocrinol Metab. 2017; 28(12):831-842. PMC: 5701860. DOI: 10.1016/j.tem.2017.10.003. View

4.
Ascenzi F, De Vitis C, Maugeri-Sacca M, Napoli C, Ciliberto G, Mancini R . SCD1, autophagy and cancer: implications for therapy. J Exp Clin Cancer Res. 2021; 40(1):265. PMC: 8383407. DOI: 10.1186/s13046-021-02067-6. View

5.
Badur M, Muthusamy T, Parker S, Ma S, McBrayer S, Cordes T . Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Sells. Cell Rep. 2018; 25(4):1018-1026.e4. PMC: 6613636. DOI: 10.1016/j.celrep.2018.09.074. View